Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosynthesis, processing, and sorting of human myeloperoxidase.

Markus Hansson1, Inge Olsson, William M Nauseef

  • 1Department of Hematology, C14, BMC, SE-221 84 Lund, Sweden. Markus.Hansson@med.lu.se

Archives of Biochemistry and Biophysics
|September 27, 2005
PubMed
Summary

Myeloperoxidase (MPO) is crucial for host defense but also linked to inflammatory diseases. Mutations causing MPO deficiency reveal insights into its complex biosynthesis, processing, and cellular targeting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials.

Haematologica·2026
Same author

Myeloid-Derived Suppressor Cells (MDSCs) Suppress T-Cell Proliferation Less Than Mature Neutrophils in Blood and Bone Marrow From Multiple Myeloma Patients.

Journal of immunology research·2026
Same author

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study.

Leukemia·2026
Same author

Myeloperoxidase gene knockout causes local inflammation and dysbiosis in the murine gut.

Gut microbes reports·2025
Same author

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.

The New England journal of medicine·2025
Same author

Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases.

Leukemia·2025

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Myeloperoxidase (MPO) is synthesized by neutrophils and monocytes, playing a dual role in host defense and inflammatory tissue damage (e.g., atherosclerosis).
  • MPO biosynthesis involves complex intracellular processing, including N-glycosylation, chaperone interactions, heme incorporation, and proteolytic cleavage within specific cellular compartments.

Purpose of the Study:

  • To investigate the structural determinants governing MPO biosynthesis, processing, and targeting.
  • To understand the functional significance of the MPO propeptide in normal protein maturation and localization.

Main Methods:

  • Analysis of naturally occurring mutations leading to inherited MPO deficiency.
  • Characterization of MPO precursor processing and targeting pathways.

Related Experiment Videos

Main Results:

  • The MPO propeptide is essential for correct processing and targeting; its deletion results in degradation or constitutive secretion.
  • Mutations causing MPO deficiency offer insights into the molecular mechanisms underlying MPO maturation and localization.

Conclusions:

  • Understanding MPO processing and targeting is critical for comprehending its role in both immunity and disease.
  • Inherited MPO deficiency provides a valuable model for dissecting the intricate steps of MPO biogenesis and function.